BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• 

  Obesity

  Lilly’s tirzepatide will be biggest blockbuster ever, topping $70B by 2032: Evaluate

  Eli Lilly’s weight-loss franchise—including the tirzepatide products Mounjaro and Zepbound, and the weight-loss pill Foundayo—is projected to account for nearly half of the total sales of the top 10 drugs in 2032.

  June 23, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Inflammatory bowel disease

  Merck posts ‘encouraging’ Phase 3 ulcerative colitis data but Roche challenge looms

  Given its intravenous route of administration, Merck’s tulisokibart will likely “need to be meaningfully improved” over Roche’s afimkibart, which can be given subcutaneously, BMO Capital Markets analysts said. Both assets are being tested for ulcerative colitis.

  June 23, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Entact Bio Appoints John G. Houston, Ph.D., to its Board of Directors

  June 23, 2026

   · 

  3 min read
• Press Releases

  Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

  June 23, 2026

   · 

  12 min read
• Press Releases

  Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC)

  June 23, 2026

   · 

  7 min read
• Press Releases

  Plus Therapeutics to Provide Business Update Call on June 30, 2026

  June 23, 2026

   · 

  4 min read
• Press Releases

  Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market

  June 23, 2026

   · 

  8 min read
• Press Releases

  Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT

  June 23, 2026

   · 

  4 min read
• Press Releases

  European Commission Approves Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer Patients Not Candidates for PD-(l)1 Inhibitors

  June 23, 2026

   · 

  16 min read
• Press Releases

  BostonGene to Present AI Innovations at BIO 2026

  June 23, 2026

   · 

  2 min read